A selection of major announcements

1. Ganfeng Lithium and Hyundai Motor sign “Long-term Supply Agreement”

$GANFENGLITHIUM (01772.HK)$An announcement was issued. Recently, the company signed a “Long-term Supply Agreement” with Hyundai Motor, agreeing that the company and its subsidiaries will supply battery-grade lithium hydroxide products to Hyundai. The supply quantity for each year will be carried out in accordance with the agreement, and the actual purchase quantity and sales amount shall be subject to the final purchase order.

2. Yancoal Australia: Commercial coal sales volume for the full year of 2023 was 33.1 million tons, up 13% year on year

$YANCOAL AUS (03668.HK)$An announcement was issued. In the fourth quarter of 2023, commercial coal production was 9.7 million tons, up 47% year on year; commercial coal sales were 10.1 million tons, up 46% year on year; average coal sales price was 196 Australian dollars/ton. In 2023, commercial coal production was 33.4 million tons, up 14% year on year; commercial coal sales were 33.1 million tons, up 13% year on year; average coal sales price was 232 Australian dollars/ton.

3. Shijiyao Group: Potassium chloride injection approved to pass consistent evaluation of generic drug quality and efficacy

$SSY GROUP (02005.HK)$According to the announcement, the group's potassium chloride injection (20ml: 3.0 g) has obtained approval from China's State Drug Administration to pass the consistent evaluation of generic drug quality and efficacy, and is the first domestic company to be approved. Potassium chloride injection (20ml: 3.0g) is mainly used to treat and prevent hypokalemia, and is suitable for when oral potassium supplementation is not possible.

4. Nai Xue's Tea: Net 214 stores directly managed by Nai Xue's tea were added in the fourth quarter

$NAYUKI (02150.HK)$An announcement was issued. In the three months ended December 31, 2023, the Group obtained a net addition of 214 stores directly managed by Nai Xue's tea and the closure of 14 stores directly managed by Nai Xue's tea. As of December 31, 2023, the Group operated a total of 1,574 stores directly managed by Nayuki's tea. In terms of store expansion, the Group added a net total of 506 stores directly managed by Nayue's tea in 2023, and is expected to open about 200 new stores directly managed by Nayue's tea in 2024.

5. Tencent Holdings spent HK$1.03 billion to buy back 3.64 million shares on January 18

$TENCENT (00700.HK)$An announcement was issued to repurchase 3.64 million shares at HK$1,003 billion on January 18, 2024, at a repurchase price of HK$271.2-278.8 per share.

6. Meituan-W spent HK$400 million to buy back 5.7306 million shares on January 18

$MEITUAN-W (03690.HK)$An announcement was issued to repurchase 5.7306 million shares at HK$400 million on January 18, 2024, at a repurchase price of HK$68.4-71.35 per share.

IPO News

$Yibin City Commercial Bank Co Ltd (810517.HK)$The Hong Kong stock IPO was filed, and the largest shareholder is Wuliangye Group

$Qunabox Group Limited (810534.HK)$The Hong Kong stock IPO was registered, making it a leading domestic AIoT marketing solution provider

Financial data

$EEKA FASHION (03709.HK)$Fa Yingxi expects annual net profit to increase by more than 120% year on year

$ANE (09956.HK)$Fa Yingxi expects to obtain a non-Hong Kong financial reporting standard profit of not less than 500 million yuan in 2023, turning a year-on-year loss into a profit

Operational data

$YANCOAL AUS (03668.HK)$: Commercial coal sales for the full year of 2023 were 33.1 million tons, up 13% year on year

$NAYUKI (02150.HK)$: Net addition of 214 stores directly managed by Nayuki's tea in the fourth quarter

Company news

$GANFENGLITHIUM (01772.HK)$Signed a “long-term supply agreement” with Hyundai

$SSY GROUP (02005.HK)$: Potassium chloride injection approved through consistent evaluation of generic drug quality and efficacy

$DEKON AGR (02419.HK)$The “full circulation” of domestic unlisted shares has been registered

$XD INC (02400.HK)$Further repurchase of convertible bonds with a total principal amount of $30 million

$SIMCERE PHARMA (02096.HK)$: The “New England Journal of Medicine” published the results of a phase II/III clinical study of the innovative anti-COVID-19 drug Senoxin® in the treatment of adult patients with mild to moderate COVID-19

$CHUNLI MEDICAL (01858.HK)$A total of 580 million yuan of structured deposit products from the Bank of Beijing were subscribed

Equity incentives

$ZAI LAB (09688.HK)$Issuance of 3.7 million shares under the share award scheme

$GUSHENGTANG (02273.HK)$: The trustee purchased 94,600 shares under the restricted share award scheme

$NEWBORNTOWN (09911.HK)$: Three D Partners buys an additional 5.198,000 shares in connection with the Restricted Share Unit Incentive Program

$ZHIHU-W (02390.HK)$Grant of 3,0989 million restricted share units under the share incentive plan

Repurchase cancellation

$TENCENT (00700.HK)$On January 18, HK$1.03 billion was spent to buy back 3.64 million shares

$MEITUAN-W (03690.HK)$On January 18, HK$400 million was spent to buy back 5.7306 million shares

$HSBC HOLDINGS (00005.HK)$On January 17, HK$175 million was spent to buy back 3 million shares

$AIA (01299.HK)$On January 18, it cost about HK$165 million to repurchase 2.8 million shares

$XIAOMI-W (01810.HK)$On January 18, it cost about HK$93.374 million to buy back 7 million shares

$KUAISHOU-W (01024.HK)$On January 18, approximately HK$39.95 million was spent to buy back 932,000 shares

$KINGDEE INT'L (00268.HK)$On January 18, it cost about HK$285.978 million to buy back 3 million shares

$WUXI BIO (02269.HK)$On January 18, it cost approximately HK$22.864,600 to buy back 785,000 shares

$CHINA MOBILE (00941.HK)$On January 18, about HK$22.843,700 was spent to buy back 353,000 shares

$ESR (01821.HK)$On January 18, approximately HK$21.748 million was spent to repurchase 2.1 million shares

$COSCO SHIP HOLD (01919.HK)$On January 18, 2.58 million shares were purchased at a cost of approximately HK$20.34 million

$CHINASOFT INT'L (00354.HK)$On January 18, approximately HK$15.787,500 was spent to buy back 3 million shares

$SWIRE PACIFIC A (00019.HK)$On January 18, approximately HK$13.09 million was spent to repurchase 21,55,500 shares

$SKYWORTH GROUP (00751.HK)$On January 18, approximately HK$10.6019 million was spent to buy back 3.556 million shares

$WUXI APPTEC (02359.HK)$On January 18, 154.67,500 purchased bonus shares were cancelled

editor/tolk